Page 17 - Read Online

Page 12 of 13 Tong et al. Hepatoma Res 2019;5:36 I http://dx.doi.org/10.20517/2394-5079.2019.005

Authors’ contributions
Study concept and design: Tong MJ
Acquisition of data: Kaki DA, Huynh CT
Analysis and interpretation of data: Tong MJ, Raman SS, Lu DS
Drafting the manuscript: Tong MJ, Kaki DA, Raman SS, Lu DS
Critical revision of the manuscript: Tong MJ, Raman SS, Lu DS

Availability of data and materials
Not applicable.

Financial support and sponsorship
None.

Conflicts of interest
All authors declared that there are no conflicts of interest.

Ethical approval and consent to participate
Not applicable.

Consent for publication
Not applicable.

Copyright
© The Author(s) 2019.

REFERENCES
1. Bertuccio P, Turati F, Carioli G, Rodriguez T, La Vecchia C, et al. Global trends and predictions in hepatocellular carcinoma mortality.
J Hepatol 2017;67:302-9.
2. Rahib L, Smith BD, Aizenberg R, Rosenzweig AB, Fleshman JM, et al. Projecting cancer incidence and deaths to 2030: the
unexpected Burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res 2014;74:2913-21.
3. Jinjuvadia R, Salami A, Lenhart A, Jinjuvadia K, Liangpunsakul S, et al. Hepatocellular carcinoma: a decade of hospitalizations and
financial Burden in the United States. Am J Med Sci 2017;354:362-9.
4. de Martel C, Maucort-Boulch D, Plummer M, Franceschi S. World-wide relative contribution of hepatitis B and C viruses in
hepatocellular carcinoma. Hepatology 2015;62:1190-200.
5. Tong MJ, Rosinski AA, Huynh CT, Raman SS, Lu DSK. Long-term survival after surveillance and treatment in patients with chronic
viral hepatitis and hepatocellular carcinoma. Hepatol Commun 2017;1:595-608.
6. Sheu JC, Sung JL, Chen DS, Yang PM, Lai MY, et al. Growth rate of asymptomatic hepatocellular carcinoma and its clinical
implications. Gastroenterology 1985;89:259-66.
7. Taouli B, Goh JSK, Lu Y, Qayyum A, Yeh BM, et al. Growth rate of hepatocellular carcinoma: evaluation with serial computed
tomography or magnetic resonance imaging. J Comput Assist Tomogr 2005;29:425-9.
8. Okazaki N, Yoshino M, Yoshida T, Suzuki M, Moriyama N, et al. Evaluation of the prognosis for small hepatocellular carcinoma
based on tumor volume doubling time: a preliminary report. Cancer 1989;63:2207-10.
9. Cucchetti A, Vivarelli M, Piscaglia F, Nardo B, Montalti R, et al. Tumor doubling time predicts recurrence after surgery and describes
the histological pattern of hepatocellular carcinoma on cirrhosis. J Hepatol 2005;43:310-6.
10. Park Y, Choi D, Lim HK, Rhim H, Kim Y, et al. Growth rate of new hepatocellular carcinoma after percutaneous radiofrequency
ablation: evaluation with multiphase CT. Am J Roentgenol 2008;191:215-20.
11. Mehrara E, Forssell-Aronsson E, Ahlman H, Bernhardt P. Specific growth rate versus doubling time for quantitative characterization
of tumor growth rate. Cancer Res 2007;67:3970-5.
12. Bruix J, Sherman M. Management of hepatocellular carcinoma: an update. Hepatology 2011;53:1020-2.
13. Bruix J, Sherman M; Proactive Guidelines Committee; American Association for the Study of Liver Disease. Managemtn of
hepatocellular carcinoma. Hepatology 2005;42:1208-36.
14. Schwartz M. A Biomathematical approach to clinical tumor growth. Cancer 1961;14:1272-94.
15. Breiman L. Classification and Regression Trees. Boca Raton: Chapman & Hall [u.a.]; 1998. p. 358.
16. Siripongsakun S, Lee JK, Raman SS, Tong MJ, Sayre J, et al. MRI detection of intratumoral fat in hepatocellular carcinoma: potential
biomarker for a more favorable prognosis. Am J Roentgenol 2012;199:1018-25.
17. Lu DS, Siripongsakun S, Kyong Lee J, Wei SH, Cheng PM, et al. Complete tumor encapsulation on magnetic resonance imaging: a